A stage I pilot study of acceptance and commitment therapy for methadone detoxification

Area of Science:

• Behavioral science
• Psychology
• Addiction medicine

Background:

• Opioid dependence treatment often relies on detoxification, but success rates are low due to withdrawal symptoms.
• Existing behavioral therapies inadequately address the psychological distress of opioid withdrawal.
• Acceptance and Commitment Therapy (ACT) posits that avoiding unpleasant experiences can be detrimental, leading to treatment dropout and continued substance use.

Purpose of the Study:

• To develop and pilot test a novel behavioral therapy for opioid detoxification based on Acceptance and Commitment Therapy (ACT).
• To evaluate the efficacy of ACT compared to standard drug counseling (DC) in supporting patients through methadone dose reduction and detoxification.

Main Methods:

• A Stage I pilot study involved 56 opioid-dependent patients at a methadone clinic.
• Participants were randomized to receive either 24 individual sessions of ACT or drug counseling (DC).
• Both groups underwent a 6-month methadone dose reduction program.

Main Results:

• No significant difference in opioid use during treatment was observed between ACT and DC groups.
• Successful detoxification rates were higher in the ACT group (37%) compared to the DC group (19%).
• Fear of detoxification significantly decreased over time in the ACT condition relative to the DC condition.

Conclusions:

• This initial study suggests ACT is a promising behavioral intervention to enhance opioid detoxification outcomes.
• Further research is warranted to refine ACT strategies for this patient population and maximize treatment effects.
• ACT may offer a valuable alternative or adjunct to traditional therapies for opioid withdrawal management.